Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Share-based Compensation (2021 - 2025)

Rxo (RXO) has disclosed Share-based Compensation for 5 consecutive years, with $7.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Share-based Compensation rose 16.67% year-over-year to $7.0 million, compared with a TTM value of $29.0 million through Dec 2025, up 26.09%, and an annual FY2025 reading of $29.0 million, up 26.09% over the prior year.
  • Share-based Compensation was $7.0 million for Q4 2025 at Rxo, down from $8.0 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $23.0 million in Q4 2022 and bottomed at $2.0 million in Q4 2021.
  • Average Share-based Compensation over 5 years is $6.2 million, with a median of $6.0 million recorded in 2023.
  • The sharpest move saw Share-based Compensation soared 1050.0% in 2022, then plummeted 86.96% in 2023.
  • Year by year, Share-based Compensation stood at $2.0 million in 2021, then skyrocketed by 1050.0% to $23.0 million in 2022, then tumbled by 86.96% to $3.0 million in 2023, then skyrocketed by 100.0% to $6.0 million in 2024, then increased by 16.67% to $7.0 million in 2025.
  • Business Quant data shows Share-based Compensation for RXO at $7.0 million in Q4 2025, $8.0 million in Q3 2025, and $7.0 million in Q2 2025.